Influence of Pluronic® F68 on ceftazidime biological activity in parenteral solutions

Journal of Pharmaceutical Sciences

Volumn 100, Issue 2, 2011, Pages 715-720

  Dos Santos, Carolina Alves ^a   Ribeiro, Gabriel Borghesan ^a   Knirsch, Marcos Camargo ^a   Junior, Adalberto Pessoa ^a   Vessoni Penna, Thereza Christina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemical stability; Drug interactions; Injectables; Nanotechnology; Polymers

Indexed keywords

AMINOPHYLLINE; CEFTAZIDIME; POLOXAMER;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 78650570896     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22287     Document Type: Article

References (22)

1. Santos CA, Mazzola PG, Silva PHS, Cholewa O, Penna TCV. 2007. Preliminary study on the potential utility of GFP as a biosensor for drug stability in parenteral solutions. Biotechnol Prog 23(4):979-984.
2. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H. 2006. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient antibiotic use in Europe. J Antimicrob Chemother 58(2):401-407.
3. Moriyama B, Henning SA, Neuhauser M. 2009. Continuous-infusion of β-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant Gram-negative bacteria. Ann Pharmacother 43:1327-1337.
4. Riethmueler J, Junge J, Schroeter TW, Kuemmerer K, Franke P, Ballmann M, Claass A, Broemme S, Jeschke R, Hebestreit A, Staab D, Koetz K, Doering G, Stern M. 2009. Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis. Infection 37(5):418-423.
5. Pleasants RA, Vaughan LM, Williams M, Fox JL. 1992. Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion. Ann Pharmacother 26:1221-1226.
6. McLaughlin GE, Land MP, Rossique-Gonzalez M. 2004. Effect of aminophylline on urine flow in children with tacrolimus induced renal insufficiency. Transplant Proc 32:817-820.
7. Croy SR, Kwon GS. 2004. The effects of Pluronic block copolymers on the aggregation state of nystatin. J Control Release 95(2):161-171.
8. Batrakova EV, Kabanov AB. 2008. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 130:98-106.
9. Ma WD, Xu H, Wang C, Nie SF, Pan WS. 2008. Pluoronic F127 gpoly(acrylic acid) copolymers as In Situ gelling vehicle for ophthalmic drug delivery system. Int J Pharm 350:247-256.
10. Oh TK, Bronich KT, Kabanov VA. 2004. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J Control Release 94:411-422.
11. Kwon GS, Naito M, Kataoka K, Yokoyama M, Sakurai Y, Okano T. 1994. Block copolymer micelles as vehicles for hydrophobic drugs. Colloids Surf B 15:429-434.
12. Kwon GS. 1998. Diblock copolymer nanoparticles for drug delivery. Crit Rev Ther Drug Carrier Syst 15:481-512.
13. Batrakova EV, Lee S, Li S, Venne A, Alakhov V, Kabanov A. 1999. Fundamental relationships between the compositions of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 16(9):1373-1379.
14. Kabanov VA, Batrakova VE, Alakhov YV. 2003. Essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J Control Release 91:75-83.
15. Spitzenberger TJ, Heilman D, Diekmann C, Batrakova EV, Kabanov AV, Gendelman HE, Elmquist WF, Persidsky Y. 2007. Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis. J Cereb Blood Flow Metab 27(5):1033-1042.
16. Briones E, Colino IC, Lanao MJ. 2008. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release 125:210-227.
17. The United States Pharmacopeial Convention, Inc., The United States Pharmacopoeia, 31st revision. 2008. Rockville, MD: The United States Pharmacopeial Convention, Inc., pp 67-76.
18. Ortega SJM, Reyes JBA, Csaba N, Gonzalez BD, Vinuesa OLJ. 2006. Colloidal stability of Pluoronic F68-coated PLGA nanoparticles: A variety of stabilization mechanisms. J Colloid Interface Sci 302:522-529.
19. Torchilin VP. 2007. Nanocarriers. Pharm Res 12:2333-2334.
20. Torchilin VP. 2007. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm 71:431-444.
21. Wolff M, Pranzas K, Magerl A, Zabel H. 2007. Crystallization of F68 micelles. Superlattices Microstruct 41:190-195.
22. Yi X, Batrakova EV, Banks W, Vinagradov S, Kabanov AV. 2008. Protein conjugation with amphiphilic copolymers for enhanced cellular delivery. Bioconjug Chem 19:1071-1077.